Ultragenyx Pharmaceutical Inc. (RARE) Total assets 2016–2025
Ultragenyx Pharmaceutical Inc. (RARE) total assets at each fiscal year-end, per SEC filings.
$1.5BFY2025 · since FY2016: $540.6M → $1.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5B | +1.9% |
| FY2024 | $1.5B | +0.8% |
| FY2023 | $1.5B | -3.5% |
| FY2022 | $1.5B | +1.5% |
| FY2021 | $1.5B | -13.5% |
| FY2020 | $1.8B | +55.0% |
| FY2019 | $1.1B | +57.8% |
| FY2018 | $719.6M | +46.6% |
| FY2017 | $490.8M | -9.2% |
| FY2016 | $540.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice